Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TBC1D22A divergent transcript (TBC1D22A-DT) is a long non-coding RNA gene located adjacent to the protein-coding gene TBC1D22A on the human genome. It functions as a cis-regulatory element, likely controlling the expression of the nearby TBC1D22A gene. There is currently minimal information regarding its direct role in disease, biological mechanisms, or therapeutic relevance. TBC1D22A-DT should not be confused with TBC1D22A itself, a protein-coding gene involved in intracellular vesicle transport and implicated in cancer and neurological diseases.
No mechanisms of drug action are known for TBC1D22A-DT.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TBC1D22A divergent transcript (TBC1D22A-DT).